Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3
Clinical trial NCT01616524 · COMPLETED
Trial details
- NCT number
- NCT01616524
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-06-01
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.